#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Slovenia

  • A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

    Recruiting

    3 1
    Investigated drugs:
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia Finland +9

  • A Study of Gene Replacement Therapy for Children with CTNNB1 Syndrome Using Adeno-Associated Viral Vector Serotype 9 Containing the Human CTNNB1 Gene

    Recruiting

    2 1 1
    Investigated diseases:
    • Neurodevelopmental disorder
    Investigated drugs:
    • ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CTNNB1 GENE
    Slovenia

  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6

  • A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

    Recruiting

    3 1
    Investigated diseases:
    • Secondary progressive multiple sclerosis
    Investigated drugs:
    • Remibrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1
    Investigated drugs:
    • Empasiprubart
    • Human Normal Immunoglobulin (Iv)
    Austria Bulgaria Czechia Denmark Estonia France +13

  • A study to evaluate the safety of dazodalibep in patients with Sjögren’s Syndrome over a long period of time

    Recruiting

    3 1 1
    Investigated diseases:
    • Sjogren’s syndrome
    Investigated drugs:
    • Dazodalibep
    Belgium Croatia Denmark France Germany Greece +6
1 2 3 … 16
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Carboplatin Guselkumab Iptacopan Pembrolizumab Empasiprubart Vincristine Sulfate Semaglutide Lutikizumab Cyclophosphamide Risankizumab Dazodalibep (S)-2-Amino-6-(2-Hydroxypropanoyl)-7,8-Dihydropteridin-4(3H)-One Golimumab Remibrutinib Cisplatin Bhv-7000 Inclisiran Dexamethasone Ocrelizumab Human Normal Immunoglobulin (Iv) Methylprednisolone Sodium Succinate Rosuvastatin Dapagliflozin Doxorubicin Somapacitan Etoposide Somatropin 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol Temozolomide Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acquired antithrombin III deficiency Acute myeloid leukaemia Acute myocardial infarction Amyotrophic lateral sclerosis Anal incontinence Antibiotic therapy Arteriosclerosis Asthma Atypical haemolytic uraemic syndrome B-cell type acute leukaemia Breast cancer Cardiac failure Cardiogenic shock Chronic inflammatory demyelinating polyradiculoneuropathy Colitis ulcerative Colon cancer Critical illness Crohn's disease Cytomegalovirus infection Dementia Alzheimer's type Dermatitis atopic Duchenne muscular dystrophy Endocrine ophthalmopathy Endometrial cancer Endometrial cancer metastatic Erythema migrans Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Glycogen storage disease type II Growth hormone deficiency Heparin resistance Hidradenitis Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Human epidermal growth factor receptor negative Hyperlipidaemia Hypertension Idiopathic pulmonary fibrosis IgA nephropathy Interstitial lung disease Kidney transplant rejection Malignant glioma Malignant melanoma Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myocarditis Myocarditis post infection Neonatal alloimmune thrombocytopenia Neuroblastoma Neurodevelopmental disorder Non-small cell lung cancer Non-small cell lung cancer stage III Noonan syndrome Ovarian cancer Pancreatic carcinoma metastatic Partial seizures Phenylketonuria Plasma cell myeloma refractory Prostate cancer Psoriatic arthropathy Pulmonary embolism Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Rhabdomyosarcoma Secondary progressive multiple sclerosis Short stature Sjogren's syndrome Small for dates baby Squamous cell carcinoma of head and neck Turner's syndrome Type 1 diabetes mellitus Type 2 diabetes mellitus Type IIa hyperlipidaemia Vascular malformation Viral myocarditis

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!